The results suggest that elevated anti-GNAS autoantibody which was present in very early-stage HCC patients may result from the higher expression of GNAS protein in HCC tissues, thus autoantibody to GNAS has more potential to be an indicator for the early detection of HCC. The gene discussed is GNAS; the disease is hepatocellular carcinoma.